Longfellow Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.9M | Buy |
148,983
+128,038
| +611% | +$5.93M | 1.71% | 11 |
|
|
2025
Q1 | $1.28M | Sell |
20,945
-127,573
| -86% | -$7.78M | 0.31% | 46 |
|
|
2024
Q4 | $8.4M | Sell |
148,518
-2,378
| -2% | -$135K | 2.16% | 9 |
|
|
2024
Q3 | $7.81M | Buy |
150,896
+239
| +0.2% | +$12.4K | 1.95% | 14 |
|
|
2024
Q2 | $6.26M | Buy |
150,657
+119,681
| +386% | +$4.97M | 1.57% | 15 |
|
|
2024
Q1 | $1.68M | Buy |
30,976
+6,107
| +25% | +$331K | 0.38% | 30 |
|
|
2023
Q4 | $1.28M | Hold |
24,869
| – | – | 0.31% | 38 |
|
|
2023
Q3 | $1.44M | Buy |
24,869
+2,634
| +12% | +$153K | 0.38% | 37 |
|
|
2023
Q2 | $1.42M | Buy |
22,235
+904
| +4% | +$57.8K | 0.33% | 41 |
|
|
2023
Q1 | $1.48M | Buy |
21,331
+10,717
| +101% | +$743K | 0.34% | 38 |
|
|
2022
Q4 | $764K | Hold |
10,614
| – | – | 0.17% | 92 |
|
|
2022
Q3 | $755K | Hold |
10,614
| – | – | 0.15% | 121 |
|
|
2022
Q2 | $818K | Sell |
10,614
-15,429
| -59% | -$1.19M | 0.18% | 110 |
|
|
2022
Q1 | $1.9M | Hold |
26,043
| – | – | 0.31% | 87 |
|
|
2021
Q4 | $1.62M | Buy |
26,043
+2,170
| +9% | +$135K | 0.26% | 97 |
|
|
2021
Q3 | $1.41M | Hold |
23,873
| – | – | 0.23% | 101 |
|
|
2021
Q2 | $1.6M | Sell |
23,873
-9,739
| -29% | -$651K | 0.23% | 97 |
|
|
2021
Q1 | $2.12M | Buy |
33,612
+2,438
| +8% | +$154K | 0.26% | 96 |
|
|
2020
Q4 | $1.93M | Buy |
+31,174
| New | +$1.93M | 0.23% | 114 |
|